Clinical Trial Update: Targeted Biopsy of Carbon Nanoparticles Labelled Axillary Node for CN+ Breast Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluating targeted biopsy of axillary lymph nodes using carbon nanoparticles for clinically node-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Location and Biopsy of Axillary Lymph Nodes | NA | Status: COMPLETED